Alerts will be sent to your verified email
Verify EmailINNOVACAP
|
Innova Captab
|
Bliss GVS Pharma
|
Senores Pharmaceutic
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
18.56 % | 7.3 % | 11.02 % |
|
5yr average Equity Multiplier
|
2.12 | 1.28 | 2.25 |
|
5yr Average Asset Turnover Ratio
|
1.0 | 0.64 | 0.3 |
|
5yr Avg Net Profit Margin
|
8.6 % | 9.12 % | 15.05 % |
|
Price to Book
|
4.93 | 4.38 | 6.26 |
|
P/E
|
38.16 | 40.45 | 50.65 |
|
5yr Avg Cash Conversion Cycle
|
23.8 Days | 156.82 Days | -30.87 Days |
|
Inventory Days
|
49.23 Days | 53.4 Days | 46.48 Days |
|
Days Receivable
|
84.59 Days | 180.13 Days | 108.09 Days |
|
Days Payable
|
103.8 Days | 72.69 Days | 255.02 Days |
|
5yr Average Interest Coverage Ratio
|
22.6 | 14.96 | 4.44 |
|
5yr Avg ROCE
|
19.74 % | 14.01 % | 10.25 % |
|
5yr Avg Operating Profit Margin
|
13.54 % | 16.55 % | 22.88 % |
|
5 yr average Debt to Equity
|
0.55 | 0.08 | 0.83 |
|
5yr CAGR Net Profit
|
17.18 % | 53.73 % | 126.15 % |
|
5yr Average Return on Assets
|
8.45 % | 5.79 % | 4.54 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
50.9 % | 35.36 % | 45.82 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 1.9 % |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.32 % | 0.06 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
7.1 % | 0.0 | -0.55 % |
|
Innova Captab
|
Bliss GVS Pharma
|
Senores Pharmaceutic
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|